Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
67.1M
-
Number of holders
-
67
-
Total 13F shares, excl. options
-
37.4M
-
Shares change
-
+2.17M
-
Total reported value, excl. options
-
$1.05B
-
Value change
-
+$59M
-
Number of buys
-
37
-
Number of sells
-
-29
-
Price
-
$27.98
Significant Holders of Olema Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (OLMA) as of Q2 2021
82 filings reported holding OLMA - Olema Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share as of Q2 2021.
Olema Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (OLMA) has 67 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37.4M shares
of 67.1M outstanding shares and own 55.69% of the company stock.
Largest 10 shareholders include BVF INC/IL (6.66M shares), Logos Global Management LP (3.74M shares), JANUS HENDERSON GROUP PLC (3.22M shares), Cormorant Asset Management, LP (3.07M shares), VANGUARD GROUP INC (2.46M shares), RA CAPITAL MANAGEMENT, L.P. (2.15M shares), WELLINGTON MANAGEMENT GROUP LLP (1.62M shares), VR Adviser, LLC (1.54M shares), BlackRock Inc. (1.47M shares), and CITADEL ADVISORS LLC (1.44M shares).
This table shows the top 67 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.